Hong Chen
Has grant
Professor of Surgery
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Recent Grants
Grant: Open
A New-Generation Lipid-Lowering and Anti-Inflammatory siRNA Therapy for Atherosclerosis
Open Date: 2025-09-15
Close Date: 2029-06-30
Grant: Open
Targeting Endothelial Epsins to Ameliorate Myocardial Ischemia
Open Date: 2024-07-08
Close Date: 2028-06-30
Grant: Open
Targeting Epsins to Develop Therapeutics for Familial Hypercholesterolemia
Open Date: 2024-07-01
Close Date: 2027-06-30
Grant: Close
The Pro-angiogenic Molecular Mechanisms Controlling Cardiovascular Diseases
Open Date: 2023-07-01
Close Date: 2026-06-30
Grant: Open
The Role of Adaptor Protein Disabled-2 in Maintaining Endothelial Cell Function in Atherosclerosis
Open Date: 2021-12-01
Close Date: 2026-11-30
Articles (20)
Year:
2026
Year:
2025
Cell-cell communication (CCC) is crucial for cellular function and tissue homeostasis. Existing methods for protein-oriented CCC detection often overlook metabolite-mediated CCC (mCCC), and adapting them to mCCC analysis is challenging due to fundamental differences in the underlying biological mechanisms. To fill this gap, we developed MEBOCOST, an algorithm built on scRNA-seq and metabolic flux balance analysis to detect mCCC among single cells. Comprehensive benchmarking analyses based on simulation, spatial, CRISPR screen, and clinical patient data demonstrated the robustness of MEBOCOST in detecting biologically significant mCCC events. We applied MEBOCOST to scRNA-seq datasets of human white adipose tissues and unraveled macrophages were the predominant source of mCCC reprogramming in obese patients. Moreover, analysis in mice brown adipose tissue successfully recapitulated known and further uncovered new mCCC events, including a glutamine-mediated endothelial-to-adipocyte communication, which was experimentally verified to regulate adipocyte differentiation. Therefore, MEBOCOST is a valuable tool for researchers investigating mCCC in diverse biological contexts and disease samples. MEBOCOST is freely available at https://github.com/kaifuchenlab/MEBOCOST.
Year:
2025
Year:
2025
Year:
2025
Year:
2025
BACKGROUND: Atherosclerosis is a chronic inflammatory disease characterized by the accumulation of lipid-laden foam cells and plaques within the arterial wall. Dysfunctional vascular smooth muscle cells (VSMCs), fibroblasts, endothelial cells, and macrophages contribute to disease progression. Here, we report that macrophage-specific expression of epsins, highly conserved endocytic adaptor proteins involved in clathrin-mediated endocytosis, accelerates atherosclerosis in Western diet–fed mice. METHODS: WT/Apoe −/− (wild-type/Apoe-deficient) mice and littermates with a LysM-DKO/Apoe −/− (myeloid-specific deletion of epsin 1/2 on an Apoe −/− background) were generated and fed a Western diet for 16 weeks. Single-cell RNA sequencing was conducted to investigate the cellular and molecular mechanisms regulated by macrophage epsins during atherosclerosis. Findings from single-cell RNA sequencing were validated through metabolic profiling, qRT-PCR (quantitative reverse transcription polymerase chain reaction), immunostaining, and coculture experiments to assess associated phenotypic changes. RESULTS: LysM-DKO/Apoe −/− mice exhibited significantly reduced atherosclerotic foam cell formation compared with WT/Apoe −/− controls. Single-cell RNA sequencing analysis identified 19 major cell types, including 6 VSMC and 5 macrophage subpopulations. Modulated VSMC1 and VSMC2 subtypes were associated with inflammation, migration, and VSMC-to-macrophage transition. These populations, along with foamy-Trem2 and inflammatory macrophages, were markedly reduced in LysM-DKO/Apoe −/− mice. Transition of modulated VSMC2 subtype into macrophages was significantly inhibited, as confirmed by both computational analysis and experimental validation. In addition, macrophage epsin deletion reversed endothelial dysfunction, suppressed cholesterol- and glucose-mediated signaling, and reduced expression of proinflammatory ligands IL (interleukin)-1β and TNF-α (tumor necrosis factor α). CONCLUSIONS: Macrophage epsin deletion limits foam cell formation and preserves VSMC and endothelial cell phenotypes and functions. These findings reveal a potential therapeutic strategy targeting macrophage epsins to combat atherosclerosis.
Year:
2025
Efficient lymph flow is ensured by lymphatic valves (LVs). The mechanisms that regulate LV development are incompletely understood. Here, we show that the deletion of the GPCR sphingosine 1-phosphate receptor-1 (S1PR1) from lymphatic endothelial cells (LECs) results in fewer LVs. Interestingly, LVs that remained in the terminal ileum-draining lymphatic vessels were specifically dysfunctional. Furthermore, tertiary lymphoid organs (TLOs) formed in the terminal ileum of the mutant mice. TLOs in this location are associated with ileitis in humans and mice. However, mice lacking S1PR1 did not develop obvious characteristics of ileitis. Mechanistically, S1PR1 regulates shear stress signaling and the expression of the valve-regulatory molecules FOXC2 and connexin-37. Importantly, Foxc2+/− mice, a model for lymphedema-distichiasis syndrome, also develop TLOs in the terminal ileum. Thus, we have discovered S1PR1 as a previously unknown regulator of LV and TLO development. We also suggest that TLOs are a sign of subclinical inflammation that can form due to lymphatic disorders in the absence of ileitis.
Year:
2025
Deciphering cell identity genes is pivotal to understanding cell differentiation, development, and cell identity dysregulation involving diseases. Here, we introduce SCIG, a machine-learning method to uncover cell identity genes in single cells. In alignment with recent reports that cell identity genes (CIGs) are regulated with unique epigenetic signatures, we found CIGs exhibit distinctive genetic sequence signatures, e.g. unique enrichment patterns of cis-regulatory elements. Using these genetic sequence signatures, along with gene expression information from single-cell RNA-seq data, SCIG uncovers the identity genes of a cell without a need for comparison to other cells. CIG score defined by SCIG surpassed expression value in network analysis to reveal the master transcription factors (TFs) regulating cell identity. Applying SCIG to the human endothelial cell atlas revealed that the tissue microenvironment is a critical supplement to master TFs for cell identity refinement. SCIG is publicly available at https://doi.org/10.5281/zenodo.14726426 , offering a valuable tool for advancing cell differentiation, development, and regenerative medicine research.
Year:
2025
Year:
2025
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2023
Year:
2023
Year:
2023
Collaborators (13)
Yao Wei Lu
Assistant Professor
University of Southern California
Daniel L. Kiss
Assistant Professor
Houston Methodist
Duc-Huy Nguyen
Assistant Professor
University of Wisconsin-Madison
Douglas Cowan
Staff Scientist
Boston Children's Hospital
Kui Cui
Assistant Professor
Baylor College of Medicine
Margreet de Vries
Leiden University Medical Center
William Polacheck
Associate Professor
University of North Carolina at Chapel Hill
Eric Camerer
Team Leader/Research Director
INSERM
Pengchun Yu
Associate Professor
Oklahoma Medical Research Foundation
Changcheng Zhou
Professor
University of California Riverside
Hiromi Yanagisawa
Professor
University of Tsukuba
Stella Alimperti
Associate Professor
Georgetown University School of Medicine
Allon Wagner
University of California, Berkeley
Make your next move.
Prepare your application
Review drafts before you send them.